You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GLUE Sale Disclosure
Townson Sharon · SEC Form 4 · Filed Jun 1, 2026
Sale
Calculated transaction value
$119.22K
Townson Sharon Chief Scientific Officer
GLUE
Transaction date
May 29, 2026
Public filing date
Jun 1, 2026
Filing lag
Filed 3 days later
GLUE daily price context
Close on/before transaction
$19.71
May 29, 2026
First close after public filing
$17.74
Jun 2, 2026
30-day return after filing
+35.4%
Through Jul 1, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 6,000 shares @ $19.87
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-251395
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$156.06K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Monte Rosa Therapeutics, Inc. GLUE | Exercise | May 29, 2026 | $36.84K |
| Monte Rosa Therapeutics, Inc. GLUE Current | Sale | May 29, 2026 | $119.22K |
| Monte Rosa Therapeutics, Inc. GLUE | Exercise | May 29, 2026 | $0 |